Cargando…

Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer’s Disease Continuum

Background The biological diagnosis criteria of the Alzheimer’s disease (AD) suggests that previous work may misclassify the cognitive impairment caused by other factors into AD. Consequently, re-assessing the imaging profile of AD continuum is needed. Considering the high vulnerability of cortical...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xiao, Li, Kaicheng, Zeng, Qingze, Huang, Peiyu, Jiaerken, Yeerfan, Wang, Shuyue, Shen, Zhujing, Xu, Xiaojun, Xu, Jingjing, Wang, Chao, Kong, Linlin, Zhou, Jiong, Zhang, Minming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748350/
https://www.ncbi.nlm.nih.gov/pubmed/31551678
http://dx.doi.org/10.3389/fnins.2019.00904
_version_ 1783452077335248896
author Luo, Xiao
Li, Kaicheng
Zeng, Qingze
Huang, Peiyu
Jiaerken, Yeerfan
Wang, Shuyue
Shen, Zhujing
Xu, Xiaojun
Xu, Jingjing
Wang, Chao
Kong, Linlin
Zhou, Jiong
Zhang, Minming
author_facet Luo, Xiao
Li, Kaicheng
Zeng, Qingze
Huang, Peiyu
Jiaerken, Yeerfan
Wang, Shuyue
Shen, Zhujing
Xu, Xiaojun
Xu, Jingjing
Wang, Chao
Kong, Linlin
Zhou, Jiong
Zhang, Minming
author_sort Luo, Xiao
collection PubMed
description Background The biological diagnosis criteria of the Alzheimer’s disease (AD) suggests that previous work may misclassify the cognitive impairment caused by other factors into AD. Consequently, re-assessing the imaging profile of AD continuum is needed. Considering the high vulnerability of cortical association fibers, we aimed to elucidate the cortical demyelination process in the AD continuum biologically defined. Methods According to the biological diagnosis criteria, we determined the positive amyloid status (A+) as cerebrospinal fluid (CSF) amyloid(1)(–)(42) < 192 pg/ml, Florbetapir Positron emission tomography (PET) composite standardized uptake value ratio (SUVR) >1.11. Also, the positive Tau status (T+) was determined as p-Tau(181) > 23 pg/ml. Based on the cognitive characterization, we further categorized 252 subjects into 27 cognitively unimpaired with normal AD biomarkers (A−T−, controls), 49 preclinical AD (A+T+), 113 AD with mild cognitive impairment (MCI) (A+T+), and 63 AD dementia (A+T+). We estimated the intracortical myelin content used the T1- and T2-weighted (T1W/T2W) ratio mapping. To investigate the sensitivity of the ratio mapping, we also utilized well-validated AD imaging biomarkers as the reference, including gray matter volume and Fludeoxyglucose PET (FDG-PET). Based on the general linear model, we conducted the voxel-wise two-sample T-tests between the controls and each group in the AD continuum. Results Compared to the controls, the results showed that the preclinical AD patients exhibited decreased T1W/T2W ratio value in the right inferior parietal lobule (IPL); as the disease progresses, the prodromal AD patients demonstrated lower ratio value in bilateral IPL, with hippocampus (HP) atrophy. Lastly, the AD dementia patients exhibited decreased ratio value in bilateral IPL and hippocampus; also, we observed the bilateral temporal cortices atrophy and widespread decreased metabolism in the AD dementia patients. After corrected with gray volume, the results remained mostly unchanged. Conclusion Our study implied the decreased right IPL T1W/T2W ratio might represent early AD-related demyelination in disease continuum. Additionally, we demonstrated that the T1W/T2W ratio mapping is an easy-to-implement and sensitive metric to assess the intracortical myelin content in AD, particularly in the early stage.
format Online
Article
Text
id pubmed-6748350
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67483502019-09-24 Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer’s Disease Continuum Luo, Xiao Li, Kaicheng Zeng, Qingze Huang, Peiyu Jiaerken, Yeerfan Wang, Shuyue Shen, Zhujing Xu, Xiaojun Xu, Jingjing Wang, Chao Kong, Linlin Zhou, Jiong Zhang, Minming Front Neurosci Neuroscience Background The biological diagnosis criteria of the Alzheimer’s disease (AD) suggests that previous work may misclassify the cognitive impairment caused by other factors into AD. Consequently, re-assessing the imaging profile of AD continuum is needed. Considering the high vulnerability of cortical association fibers, we aimed to elucidate the cortical demyelination process in the AD continuum biologically defined. Methods According to the biological diagnosis criteria, we determined the positive amyloid status (A+) as cerebrospinal fluid (CSF) amyloid(1)(–)(42) < 192 pg/ml, Florbetapir Positron emission tomography (PET) composite standardized uptake value ratio (SUVR) >1.11. Also, the positive Tau status (T+) was determined as p-Tau(181) > 23 pg/ml. Based on the cognitive characterization, we further categorized 252 subjects into 27 cognitively unimpaired with normal AD biomarkers (A−T−, controls), 49 preclinical AD (A+T+), 113 AD with mild cognitive impairment (MCI) (A+T+), and 63 AD dementia (A+T+). We estimated the intracortical myelin content used the T1- and T2-weighted (T1W/T2W) ratio mapping. To investigate the sensitivity of the ratio mapping, we also utilized well-validated AD imaging biomarkers as the reference, including gray matter volume and Fludeoxyglucose PET (FDG-PET). Based on the general linear model, we conducted the voxel-wise two-sample T-tests between the controls and each group in the AD continuum. Results Compared to the controls, the results showed that the preclinical AD patients exhibited decreased T1W/T2W ratio value in the right inferior parietal lobule (IPL); as the disease progresses, the prodromal AD patients demonstrated lower ratio value in bilateral IPL, with hippocampus (HP) atrophy. Lastly, the AD dementia patients exhibited decreased ratio value in bilateral IPL and hippocampus; also, we observed the bilateral temporal cortices atrophy and widespread decreased metabolism in the AD dementia patients. After corrected with gray volume, the results remained mostly unchanged. Conclusion Our study implied the decreased right IPL T1W/T2W ratio might represent early AD-related demyelination in disease continuum. Additionally, we demonstrated that the T1W/T2W ratio mapping is an easy-to-implement and sensitive metric to assess the intracortical myelin content in AD, particularly in the early stage. Frontiers Media S.A. 2019-09-10 /pmc/articles/PMC6748350/ /pubmed/31551678 http://dx.doi.org/10.3389/fnins.2019.00904 Text en Copyright © 2019 Luo, Li, Zeng, Huang, Jiaerken, Wang, Shen, Xu, Xu, Wang, Kong, Zhou and Zhang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Luo, Xiao
Li, Kaicheng
Zeng, Qingze
Huang, Peiyu
Jiaerken, Yeerfan
Wang, Shuyue
Shen, Zhujing
Xu, Xiaojun
Xu, Jingjing
Wang, Chao
Kong, Linlin
Zhou, Jiong
Zhang, Minming
Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer’s Disease Continuum
title Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer’s Disease Continuum
title_full Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer’s Disease Continuum
title_fullStr Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer’s Disease Continuum
title_full_unstemmed Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer’s Disease Continuum
title_short Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer’s Disease Continuum
title_sort application of t1-/t2-weighted ratio mapping to elucidate intracortical demyelination process in the alzheimer’s disease continuum
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748350/
https://www.ncbi.nlm.nih.gov/pubmed/31551678
http://dx.doi.org/10.3389/fnins.2019.00904
work_keys_str_mv AT luoxiao applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT likaicheng applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT zengqingze applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT huangpeiyu applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT jiaerkenyeerfan applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT wangshuyue applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT shenzhujing applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT xuxiaojun applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT xujingjing applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT wangchao applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT konglinlin applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT zhoujiong applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum
AT zhangminming applicationoft1t2weightedratiomappingtoelucidateintracorticaldemyelinationprocessinthealzheimersdiseasecontinuum